Skip to main content
Top
Published in: Allergy, Asthma & Clinical Immunology 2/2014

Open Access 01-12-2014 | Meeting abstract

Type-III hereditary angioedema resolved by surgery

Authors: Lisa W Fu, Fanny Silviu-Dan

Published in: Allergy, Asthma & Clinical Immunology | Special Issue 2/2014

Login to get access

Excerpt

In classic hereditary angioedema, inadequate C1-inhibitor (C1-INH) failing to restrict factor-XII activity leads to increased production of bradykinin, a potent vasodilator and mediator of angioedema. Hereditary angioedema with normal C1-INH (Type-III) manifests with sporadic recurrent angioedema but normal C1-INH concentration and activity. Here, bradykinin accumulation appears dependent on Factor XII and Factor XII gene mutations are sometimes found. Type-III angioedema affects almost exclusively females, worse in pregnancy, on oral contraceptives as estrogen may increase total bradykinin. Diagnosis is difficult given the clinical heterogeneity and lack of biochemical indicators. Treatment carries various risks when given for prophylaxis and a challenge for timely administration in an acute crisis. This is the first case report in the literature of a woman whose repeated angioedema episodes resolved with surgical resection of an ovarian cyst. …
Metadata
Title
Type-III hereditary angioedema resolved by surgery
Authors
Lisa W Fu
Fanny Silviu-Dan
Publication date
01-12-2014
Publisher
BioMed Central
DOI
https://doi.org/10.1186/1710-1492-10-S2-A10

Other articles of this Special Issue 2/2014

Allergy, Asthma & Clinical Immunology 2/2014 Go to the issue